TTC39B Activators
TTC39B activators are an array of diverse chemical compounds that interact with various signaling pathways to enhance the functional activity of TTC39B. One set of activators functions by manipulating intracellular levels of cyclic AMP (cAMP), a crucial secondary messenger. By activating adenylate cyclase or inhibiting phosphodiesterase, these compounds increase cAMP levels, leading to the activation of protein kinase A (PKA). PKA, in turn, phosphorylates a spectrum of target proteins, potentially including TTC39B. This cascade results in an enhanced functional state of TTC39B. Similarly, some activators work by mimicking the action of catecholamines, directly engaging beta-adrenergic receptors and perpetuating the cAMP-PKA signaling pathway, again potentially culminating in the phosphorylation and subsequent activation of TTC39B. Other activators are cAMP analogs, designed to resist degradation and maintain prolonged PKA activation, further suggesting a sustained activation of TTC39B.
The second category of TTC39B activators involves modulating intracellular calcium levels, which activates calcium/calmodulin-dependent protein kinases (CaMKs) and protein kinase C (PKC). These kinases are integral to phosphorylation events within the cell and could specifically target TTC39B. Additionally, some activators inhibit protein phosphatases, leading to an overall increase in the phosphorylated state of cellular proteins, which may include TTC39B, indirectly promoting its activity. The alteration of lipid metabolism by certain fatty acids might also affect TTC39B by changing the lipid composition of cellular membranes and associated signaling pathways. Moreover, elements and compounds that act as enzyme cofactors or inhibitors of specific kinases, such as GSK-3, modify various signaling processes and could result in the activation of TTC39B. Lastly, compounds that activate AMPK areinvolved in the cellular energy homeostasis, which may indirectly lead to the functional activation of TTC39B through intricate cellular signaling networks.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A synthetic catecholamine that acts as a beta-adrenergic agonist elevating intracellular cAMP levels, thereby activating PKA which is known to phosphorylate proteins including TTC39B, resulting in its increased activity. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Phosphodiesterase inhibitor, which prevents the breakdown of cAMP, thereby sustaining PKA activity and potentially enhancing the phosphorylation and activation of TTC39B. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore that increases intracellular calcium levels, thereby potentially activating calcium/calmodulin-dependent protein kinases (CaMKs) which could phosphorylate and activate TTC39B. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
A diacylglycerol analog that activates protein kinase C (PKC), which may lead to phosphorylation and activation of proteins involved in the same pathways as TTC39B, thereby indirectly increasing TTC39B activity. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analog that is resistant to degradation by phosphodiesterases, leading to sustained PKA activation and potential phosphorylation and activation of TTC39B. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
A potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of various proteins, which might include TTC39B, thereby indirectly increasing its activity. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
A monounsaturated fatty acid that has been shown to alter lipid metabolism and signaling pathways, potentially affecting proteins such as TTC39B through modulation of cellular lipid composition. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
A TRPV1 agonist that increases intracellular calcium levels, which could activate CaMKs potentially leading to the phosphorylation and activation of TTC39B. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
An essential trace element that acts as a cofactor for numerous enzymes and can influence multiple signaling pathways, possibly including those that regulate the phosphorylation and activity of TTC39B. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
An element known to inhibit glycogen synthase kinase-3 (GSK-3), a kinase involved in numerous signaling pathways. Inhibition of GSK-3 could lead to altered signaling dynamics potentially resulting in activation of proteins including TTC39B. | ||||||